Limiting glutamine utilization activates a GCN2/TRAIL-R2/Caspase-8 apoptotic pathway in glutamine-addicted tumor

Rosario Yerbes1,2, Rocío Mora-Molina1, F Javier Fernández-Farrán1

  • 1Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, Avda Américo Vespucio 24, 41092, Sevilla, Spain.

Cell Death & Disease
|October 27, 2022
PubMed

Insights

Glutamine-addicted tumor cells activate a novel cell death pathway when starved of glutamine. This GCN2-regulated mechanism involves TRAIL-R2 and caspase-8, leading to apoptosis.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Metabolic Pathways

Background:

  • Cancer cells exhibit altered glutamine metabolism, creating dependence for growth and survival.
  • Understanding cell death mechanisms in these addicted cells is crucial for therapeutic strategies.

Purpose of the Study:

  • To elucidate the cell death mechanism in glutamine-addicted tumor cells upon glutamine metabolism limitation.
  • To identify key molecular players and signaling pathways involved in this process.

Main Methods:

  • Induction of glutamine starvation in tumor cells.
  • Analysis of apoptotic pathways, including FADD, caspase-8, and TRAIL-R2.
  • Investigation of the role of general control nonderepressible-2 kinase (GCN2) and its signaling.
  • Assessment of FLICE-inhibitory protein (FLIP) regulation.
  • Pharmacological inhibition of transaminases and supplementation with non-essential amino acids (NEAA) and α-ketoglutarate.

Main Results:

  • Glutamine starvation triggers FADD, caspase-8, and mitochondria-dependent apoptosis involving TRAIL-R2.
  • GCN2 activation in glutamine-depleted cells upregulates TRAIL-R2, activates caspase-8, and induces apoptosis.
  • Methionine starvation-induced GCN2 signaling also promotes TRAIL-R2 upregulation and apoptosis.
  • Pharmacological inhibition of transaminases activates a GCN2/TRAIL-R2-dependent apoptotic pathway, sensitive to NEAA.
  • Metabolic stress leads to GCN2-independent FLIP downregulation, facilitating caspase-8 activation.
  • Downregulation of FLIPL and apoptosis are inhibited by α-ketoglutarate.

Conclusions:

  • A novel GCN2-regulated cell death mechanism is activated in glutamine-depleted tumor cells.
  • This pathway involves the TRAIL-R2-mediated activation of the extrinsic apoptotic pathway.
  • Targeting glutamine metabolism can induce apoptosis through this newly identified mechanism.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.8K